Evogene News

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsOct 31 09:31 ET

Evogene Price Target Cut to $12.00/Share From $30.00 by Lake Street

Dow JonesAug 23 10:07 ET

Evogene Analyst Ratings

BenzingaAug 23 09:57 ET

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Cuts Target Price to $12

Moomoo NewsAug 23 08:33 ET

Lake Street Maintains Evogene(EVGN.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 22 09:31 ET

Evogene (EVGN) Gets a Buy From Lake Street

TipRanksAug 22 08:59 ET

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)

TipRanksMay 21 09:05 ET

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)

TipRanksApr 11 08:02 ET

Evogene (EVGN) Receives a Buy From Lake Street

TipRanksApr 1 09:01 ET

Lake Street Sticks to Their Buy Rating for Evogene (EVGN)

TipRanksMar 5 09:00 ET

Buy Rating Affirmed on Evogene's Growth Potential and Commercial Ramp-Up in 2024

TipRanksMar 1 07:46 ET

Evogene (EVGN) Gets a Buy From Lake Street

TipRanksFeb 20 08:45 ET

Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Evogene (EVGN)

TipRanksNov 14, 2023 08:50 ET

Evogene's Resilience and Financial Stability Amid Middle East Tensions: A Buy Rating Analysis

TipRanksOct 16, 2023 08:15 ET

Evogene Analyst Ratings

BenzingaOct 2, 2023 08:22 ET

Lake Street Maintains Buy on Evogene, Raises Price Target to $3

BenzingaAug 18, 2023 11:10 ET

Evogene Analyst Ratings

BenzingaAug 18, 2023 11:09 ET

Evogene (EVGN) Receives a Buy From Lake Street

TipRanksAug 17, 2023 13:35 ET

Evogene Analyst Ratings

BenzingaJul 21, 2023 13:17 ET

Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS) and Evogene (EVGN)

TipRanksJun 21, 2023 14:10 ET